Cutera, Inc. (CUTR) announced that it is postponing indefinitely the release of its TruSculpt body contouring product.
Kevin Connors, CEO commented, "We have had the opportunity to review recent clinical data from our research and have determined that established clinical protocols have not yielded the desired outcome. We believe the potential market for non-invasive body contouring is very large; however, our standards for product performance are higher than is commercially available. We have a strong history of introducing leading products with a high level of clinical efficacy that ensure customer success."
He concluded, "We will continue our research efforts, including the monitoring of our clinical sites, and will commercialize the technology, if and when it has met the standards our customers have come to expect from us. This decision will allow us to redirect some of our resources on other exciting development projects."
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.